The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,310.00
Bid: 2,320.00
Ask: 2,325.00
Change: 0.00 (0.00%)
Spread: 5.00 (0.216%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,310.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract win

22 Mar 2019 07:00

RNS Number : 6581T
Oxford Instruments PLC
22 March 2019
 

Release date: 22 March 2019

Oxford Instruments and Chinese Academy of Sciences strengthen ties

 

Advanced cryogenic systems to be supplied to new laboratory facilities at the Chinese Academy's Institute of Physics

 

Oxford Instruments, a leading provider of high technology products and systems for industry and research, today announces winning the global tender to supply its market leading cryogenic equipment to the Institute of Physics-Chinese Academy of Sciences ("IOP-CAS") - a renowned research institute in fundamental study of condensed matter physics. Multiple advanced cryogenic systems will be installed at a new "Synergistic Extreme Conditions User Facility" at the Huairou Science City development in Beijing. This new collaboration further strengthens the long-standing relationship between Oxford Instruments and the IOIP-CAS, building on the performance and reliability of the many systems previously provided by Oxford Instruments to IOP-CAS's existing laboratories.

 

The supply agreement encompasses state-of-the-art superconducting magnet systems together with advanced dilution refrigerator systems, which will help to establish a world-leading synergetic user facility that integrates various extreme conditions. This will allow researchers to make ground breaking discoveries of new material states, states of matter and novel phenomena, furthering our understanding of the structure, properties and performance of these materials on a quantum scale. The complete suite of systems will be delivered to IOP-CAS in a staged plan through 2020 and 2021.

 

Ian Barkshire, Chief Executive of Oxford Instruments, commented: "This is an excellent example of the growth we are seeing from customers involved in Physical Science Research and Quantum Technologies where our key enabling technologies and advanced solutions enable fundamental research and accelerate our customers applied R&D. We are delighted to be the provider of choice to the renowned Institute of Physics in Beijing. This underlines Oxford Instruments' status as a world leader in state-of-the art technology solutions that create unique environments and enable measurements down to the molecular and atomic level."

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

For further information please contact:

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst / Luke Briggs

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTJBMTTMBJTTTL
Date   Source Headline
2nd Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 202012:07 pmRNSSecond Price Monitoring Extn
27th Feb 202012:02 pmRNSPrice Monitoring Extension
24th Feb 20207:00 amRNSDisposal of OI Healthcare business in the US
10th Feb 20201:49 pmPRNDirector/PDMR Shareholding
3rd Feb 202012:41 pmPRNTotal Voting Rights
29th Jan 20207:00 amRNSSale of Minority Share in Scienta Omicron
23rd Jan 202010:52 amPRNAdditional Listing
13th Jan 20209:55 amPRNDirector/PDMR Shareholding
10th Jan 202012:02 pmRNSPrice Monitoring Extension
9th Jan 202010:42 amPRNTotal Voting Rights
9th Jan 20209:41 amPRNBlocklisting - Interim Review
3rd Jan 20208:36 amPRNHolding(s) in Company
11th Dec 20194:03 pmPRNDirector/PDMR Shareholding
2nd Dec 20192:54 pmPRNTotal Voting Rights
12th Nov 201912:49 pmPRNDirector/PDMR Shareholding
12th Nov 20197:00 amRNSHalf-year Report
11th Oct 201912:02 pmRNSPrice Monitoring Extension
10th Oct 20194:34 pmPRNDirector/PDMR Shareholding
3rd Oct 201911:00 amPRNTotal Voting Rights
11th Sep 20193:30 pmPRNDirector/PDMR Shareholding
11th Sep 201912:12 pmPRNResult of AGM
11th Sep 201910:50 amPRNDirector/PDMR Shareholding
10th Sep 20197:00 amRNSChairman's AGM Statement 2019
29th Aug 201912:07 pmRNSSecond Price Monitoring Extn
29th Aug 201912:02 pmRNSPrice Monitoring Extension
22nd Aug 20191:24 pmPRNHolding(s) in Company
13th Aug 201910:26 amPRNDirector/PDMR Shareholding
15th Jul 20194:26 pmPRNDirector/PDMR Shareholding
11th Jul 201911:49 amPRNDirector/PDMR Shareholding
1st Jul 201911:07 amPRNBlocklisting - Interim Review
27th Jun 20195:01 pmPRNHolding(s) in Company
26th Jun 20195:30 pmRNSRPC Group
11th Jun 20191:02 pmPRNDirector/PDMR Shareholding
11th Jun 20197:00 amRNSFinal Results
30th May 20191:18 pmPRNHolding(s) in Company
13th May 201910:27 amPRNDirector/PDMR Shareholding
11th Apr 201912:00 pmPRNDirector/PDMR Shareholding
11th Apr 20197:00 amRNSTrading Statement
22nd Mar 20197:00 amRNSContract win
11th Mar 20191:40 pmPRNDirector/PDMR Shareholding
12th Feb 20191:32 pmPRNDirector/PDMR Shareholding
1st Feb 20199:56 amPRNDirector Declaration
15th Jan 201910:28 amPRNAdditional Listing
14th Jan 20194:01 pmPRNBlocklisting - Interim Review
11th Jan 201910:28 amPRNDirector/PDMR Shareholding
3rd Jan 201912:26 pmPRNDirector Declaration
2nd Jan 201911:33 amPRNHolding(s) in Company
17th Dec 20181:22 pmPRNHolding(s) in Company
12th Dec 201810:25 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.